Robin, PGY-4, and his mentor, Dr. Christine Fisher, Associate Professor of
Radiation Oncology, opened their phase I clinical trial utilizing stereotactic
body radiation therapy (SBRT) for patients with limited locoregional
recurrences of ovarian and uterine serous carcinoma. They received funding and
support from the Cancer Center for this effort. They are collaborating with Dr.
Bernard Jones in our Division of Medical Physics to learn more about the
functional imaging correlates of SBRT, and with the Human Immune Monitoring
Shared Resource (HIMSR) in the School of Medicine for analysis of novel
biologic endpoints. Dr. Robin and Dr. Fisher are excited to be able to offer
this clinical trial as a treatment option for our patients.
09/22/17: Residents Head to ASTRO to Present New Research
Current residents, Dr. Tyler
Robin, PGY-4, Dr. William Stokes, PGY-5, and Dr. Priscilla Stumpf, PGY-5, will
be presenting new research at the 2017 ASTRO Annual Meeting in San Diego, CA.
Dr. Robin will be giving an ePoster presentation entitled “Fiducial Markers are
Necessary for Accurate Delivery of Liver SBRT”. Dr. Stokes will also be giving
an ePoster presentation on “Treatment-Related Mortality Among Early-Stage NSCLC
Patients Undergoing Surgery versus SBRT”. Dr. Stumpf will be presenting a
poster on “Patterns of Care in the US Regarding Utilization of Postoperative
Radiation In Low Grade Gliomas”. Additionally, former resident, Dr. Arya Amini,
now Assistant Professor of Radiation Oncology at the City of Hope National
Medical Center, was invited to give an oral presentation on work he completed
during his residency on “Rising Rates of Upfront Surgery Followed By Radiation
in Locally Advanced Cervical Cancer”.
Accepted to Prestigious Clinical Trials Course
Supriya Jain, PGY-4, returns from the 2017 ASCO/AACR Workshop on Methods in
Clinical Cancer Research in Vail, CO. She is working on the design and
implementation of a clinical protocol under the faculty mentorship of Dr. Karyn
Goodman, entitled “Phase I Study of Dual Immune Checkpoint Blockade (Anti-PD-L1
(Durvalumab) and Anti-CTLA4 (Tremelimumab)) Plus Yttrium-90 (Y-90)
Radioembolization & Stereotactic Body Radiation Therapy (SBRT) in
Refractory Metastatic MSS (Microsatellite Stable) Colorectal Cancer with Liver
Metastases”. She continued development of this exciting protocol at this year’s
07/15/17: Robin Joins
Chartrounds.com Global Health Team
2010, Dr. Patricia Hardenbergh from the Shaw Cancer Center in Edwards, CO,
founded Chartrounds.com, a web-based platform to connect community based
radiation oncologists with disease-site experts for real time peer review and
case discussion. Building on the success of Chartrounds.com in the US, Dr.
Hardenbergh is now expanding the global reach of Chartrounds. Chartrouds.com
will launch individual sites for different global regions, and Dr. Hardenbergh
has recruited Dr. Tyler Robin, PGY-4, to lead the Chartrounds India initiative.
Check out what’s new with Chartrounds India at ind.chartrounds.com.
Receives Travel Grant for ASTRO Advocacy Day
Dr. William Stokes, PGY, 4, attends
ASTRO advocacy day with Dr. Brian Kavanagh, Professor and Chair of the
Department of Radiation Oncology. Dr. Stokes’ received a travel grant for his
trip to Capital Hill.
4/26/17: University of
Colorado Radiation Oncology Residents Recognized by Gold Humanism Honor Society
Supriya Jain, PGY-3, and Dr. Tyler Robin, PGY-3, were inducted into the
resident and fellows chapter of the Gold Humanism Honor Society.
Gives Oral Presentation at American Brachytherapy Society
William Stokes, PGY-4, was selected to give an oral presentation at the 2017
American Brachytherapy Society Annual Meeting. The title of his talk is
“Brachytherapy should not be Omitted from the Adjuvant Management of Uterine